Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
Mariëtte Labots(Dutch Cancer Society), Henk M.W. Verheul(Erasmus MC Cancer Institute)
Cited by 18
Related Papers
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
|Nature reviews. Cancer|2007|502
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
|Angiogenesis|2009|488
Platelet: transporter of vascular endothelial growth factor.
|PubMed|1997|379
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
|Nature Communications|2020|238